CTRI/2017/05/008480已完成2 期
An open-label randomized clinical study for the comparative effectiveness of constitutional homoeopathic medicine with Dysentery Compound in cases of Irritable Bowel Syndrome
ational Institute of Homoeopathy Ministry of AYUSH Govt of India0 个研究点目标入组 60 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Age 18 to 65 years
- •2. Both sexes
- •3. Symptomatic IBS for at least 2 days/week over 3 months
- •4. IBS diagnosed and sub-typed as per Rome III criteria
排除标准
- •1. Patients who are too sick for consultation
- •2. Unable to read patient information sheets and/or not giving consent to join the study
- •3. Diagnosed cases of unstable mental or psychiatric illness or other systemic disease affecting quality of life
- •4. Major gastro-intestinal surgery in last 6 months
- •5. Currently receiving standard therapy for IBS and/or undergoing homoeopathic treatment for chronic condition(s)
- •6. Pregnant and lactating women
- •7. Self-reported immune-compromised state
- •8. Substance abuse and/or dependence
研究者
相似试验
尚未招募
2 期
A clinical study on combined effect of sahacharadi syrup and ayurvedic enema therapy in sciatica.CTRI/2018/08/015289Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital
尚未招募
2 期
A combined study 0f combined effectiveness, Lodhradi Kashaya And Navaka Guggulu in patients with Madumeha (Type 2 Diabetes Mellitus)CTRI/2023/08/056755Sri Dharmasthala Manjunatheswara College of Ayurveda and
已完成
不适用
A randomized open-label prospective trial for comparing combination therapy Peg-Interferon alfa-2a (PEGASYS®) and Adefovir dipivoxil (Hepsera®) and combination therapy Peg-Interferon alfa-2a (PEGASYS®) and Tenofovir disoproxil fumarate (Viread®) versus no treatment in HBeAg negative chronic hepatitis B patients with low viral load*viral hepatitis1001965410047438chronic hepatitis BNL-OMON32978Academisch Medisch Centrum150
已完成
不适用
An open label, randomized control study for the comparison of effectiveness between Alfa-Glucosidase inhibitor and Dipeptidyl peptidase-4 (DPP-4) inhibitor in people with type 2 diabetes treated diet therapy and/or single oral hypoglycemic agentType 2 diabetesJPRN-UMIN000003503Department of Disease Control and Homeostasis, Kanazawa University Graduate School of Medical Science260
已完成
不适用
An open label, randomized control study for the comparison of pleiotropic effects between Bolus First and Basal First insulin regimens on patients with type 2 diabetesType 2 diabetesJPRN-UMIN000008369Department of Disease Control and Homeostasis, Kanazawa University Graduate School of Medical Sciences38